首页> 外国专利> 124 41 Microbial preparationpowder for formula-fed babies produced with Lactobacillus gasseri J12P4 and Staphylococcus epidermidis J4P1 isolated from Korean breast milk

124 41 Microbial preparationpowder for formula-fed babies produced with Lactobacillus gasseri J12P4 and Staphylococcus epidermidis J4P1 isolated from Korean breast milk

机译:124 41从韩国母乳中分离出的用加氏乳杆菌J12P4和表皮葡萄球菌J4P1生产的配方奶粉婴儿的微生物制剂粉

摘要

The present invention relates to a microbial medicine (powder). To induce the formation of enterobacteria similar to the same of breast-fed infants by supplying beneficial microorganisms of breast milk to bottle-fed infants (newborn babies, cesarean-born babies, and infants) who are not able to breast-feed, the microbial medicine is developed for conveniently using Lactobacillus gasseri J12P4 (KCTC 13067BP) and staphylococcus epidermidis J4P1 (KCTC 13066BP) separated from breast milk (including colostrum) of a Korean mother. To search for the antibiosis of Lactobacillus gasseri J12P4 (KCTC 13067BP) among the two microorganisms of the present invention, a growth suppression effect for Escherichia coli (ATCC 25922), which is a cause for enteritis, is confirmed through a test tube, and an enteritis suppression effect is confirmed through a medical experiment on a mouse.
机译:微生物药物(粉末)技术领域本发明涉及微生物药物(粉末)。通过向无法哺乳的奶瓶喂养婴儿(新生儿,剖宫产婴儿和婴儿)提供母乳中有益的微生物,从而诱导类似于母乳喂养婴儿的肠杆菌的形成。开发这种药物的目的是方便地使用从韩国母亲的母乳(包括初乳)中分离出来的加氏乳杆菌J12P4(KCTC 13067BP)和表皮葡萄球菌J4P1(KCTC 13066BP)。为了在本发明的两种微生物中寻找加氏乳杆菌J12P4(KCTC 13067BP)的抗微生物性,通过试管确认了引起肠炎的大肠杆菌(ATCC 25922)的生长抑制作用,通过对小鼠的医学实验证实了肠炎抑制作用。

著录项

  • 公开/公告号KR20180056896A

    专利类型

  • 公开/公告日2018-05-30

    原文格式PDF

  • 申请/专利权人 PARK SOON HI;JIN HYO SANG;

    申请/专利号KR20160154811

  • 发明设计人 PARK SOON HI;JIN HYO SANG;

    申请日2016-11-21

  • 分类号C12N1/20;A23L33;A23L33/135;A61K35/74;A61K35/747;C12R1/225;C12R1/45;

  • 国家 KR

  • 入库时间 2022-08-21 12:40:00

获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号